🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized, Phase III, multicenter, open-label study designed to evalu...
Status
Unknown
Location
Samsung Medical Center
Start Date
2019-08-27
Trial ID
NCT03991403
Treatments Being Tested
This study will evaluate the surgical safety and feasibility of atezolizuma...
Status
Terminated
Location
City of Hope Cancer Center
Start Date
2021-04-23
Trial ID
NCT04832854
Treatments Being Tested
This randomized, open-label study will evaluate the safety and efficacy of ...
Status
Completed
Location
Ironwood Cancer & Research Centers
Start Date
2015-06-11
Trial ID
NCT02367794
The goal of this research study is to evaluate the safety and feasibility o...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-05
Trial ID
NCT05774886
Treatments Being Tested
Immunotherapy is now a standard of care for first-line and eventually salva...
Status
Unknown
Location
Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet
Start Date
2020-06-26
Trial ID
NCT04465942
Treatments Being Tested
This is a Phase III, global, double-blind, 2-arm randomized study designed ...
Status
Completed
Location
St. Joseph'S Hospital & Medical Center
Start Date
2017-03-08
Trial ID
NCT03038100
Treatments Being Tested
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-30
Trial ID
NCT05238831
Treatments Being Tested
The goal of this clinical research study is to learn about the safety of ad...
Status
Active Not Recruiting
Location
MD Anderson Cancer Center
Start Date
2016-01-26
Trial ID
NCT02525757
Treatments Being Tested
This phase I/II trial tests the safety and efficacy of split-course adaptiv...
Status
Recruiting
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2023-05-09
Trial ID
NCT05501665